SE325579B - - Google Patents

Info

Publication number
SE325579B
SE325579B SE13375/65A SE1337565A SE325579B SE 325579 B SE325579 B SE 325579B SE 13375/65 A SE13375/65 A SE 13375/65A SE 1337565 A SE1337565 A SE 1337565A SE 325579 B SE325579 B SE 325579B
Authority
SE
Sweden
Application number
SE13375/65A
Inventor
H Burch
Original Assignee
Norwich Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co
Publication of SE325579B publication Critical patent/SE325579B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE13375/65A 1964-12-14 1965-10-15 SE325579B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US418311A US3324122A (en) 1964-12-14 1964-12-14 Series of 4-substituted-2-(5-nitro-2-furyl) quinazolines

Publications (1)

Publication Number Publication Date
SE325579B true SE325579B (enExample) 1970-07-06

Family

ID=23657580

Family Applications (1)

Application Number Title Priority Date Filing Date
SE13375/65A SE325579B (enExample) 1964-12-14 1965-10-15

Country Status (14)

Country Link
US (1) US3324122A (enExample)
AT (1) AT255424B (enExample)
BE (1) BE672504A (enExample)
BR (1) BR6575667D0 (enExample)
CH (1) CH448110A (enExample)
DE (1) DE1620076A1 (enExample)
DK (1) DK117902B (enExample)
ES (1) ES318292A1 (enExample)
FR (2) FR1460221A (enExample)
GB (1) GB1101179A (enExample)
IL (1) IL24359A (enExample)
NL (1) NL6513634A (enExample)
NO (1) NO118066B (enExample)
SE (1) SE325579B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542784A (en) * 1968-04-05 1970-11-24 Norwich Pharma Co 4-(hydroxyanilino)-2-(5-nitro-2-furyl)quinazolines
US3705898A (en) * 1970-01-26 1972-12-12 Morton Norwich Products Inc Certain 4 - amino - 2-(5-nitro-2-thienyl) quinazolines and the intermediate 4 - chloro-(5 - nitro-2-thienyl)quinazolines therefor
CH612432A5 (enExample) * 1975-05-12 1979-07-31 Sandoz Ag
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
EP1660486A4 (en) * 2003-08-08 2006-12-13 Ulysses Pharmaceutical Product HALOGENATED CHINAZOLINYL NITROFURANES AS ANTIBACTERIAL AGENTS
US20080146562A1 (en) * 2003-08-08 2008-06-19 Ulysses Pharmaceutical Products Inc., Halogenated quinazolinyl nitrofurans as antibacterial agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265777A (enExample) * 1960-06-09

Also Published As

Publication number Publication date
NL6513634A (enExample) 1966-06-15
FR1460221A (fr) 1966-06-17
BE672504A (enExample) 1966-03-16
GB1101179A (en) 1968-01-31
US3324122A (en) 1967-06-06
DE1620076A1 (de) 1970-02-12
AT255424B (de) 1967-07-10
BR6575667D0 (pt) 1973-09-06
ES318292A1 (es) 1967-03-01
NO118066B (enExample) 1969-11-03
DK117902B (da) 1970-06-15
FR4910M (enExample) 1967-03-13
CH448110A (de) 1967-12-15
IL24359A (en) 1969-01-29

Similar Documents

Publication Publication Date Title
FR4910M (enExample)
AU442366B2 (enExample)
BE627057A (enExample)
BE642735A (enExample)
BE642458A (enExample)
BE628611A (enExample)
BE610935A (enExample)
BE642588A (enExample)
BE642974A (enExample)
BE47396A (enExample)
BE642367A (enExample)
BE659459A (enExample)
BE613833A (enExample)
BE642104A (enExample)
BE483969A (enExample)
BE518974A (enExample)
BE642395A (enExample)
BE648284A (enExample)
BE637777A (enExample)
BE642437A (enExample)
BE642212A (enExample)
BE642114A (enExample)
BE636791A (enExample)
BE642770A (enExample)
BE658905A (enExample)